VENCO, ACHILLE
 Distribuzione geografica
Continente #
NA - Nord America 19.359
EU - Europa 13.528
AS - Asia 7.885
SA - Sud America 908
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 10
Totale 41.880
Nazione #
US - Stati Uniti d'America 19.154
IT - Italia 5.947
UA - Ucraina 2.425
SG - Singapore 2.388
CN - Cina 1.610
TR - Turchia 1.362
SE - Svezia 1.288
VN - Vietnam 1.251
DE - Germania 888
HK - Hong Kong 855
BR - Brasile 767
FI - Finlandia 739
IE - Irlanda 614
FR - Francia 564
GB - Regno Unito 493
RU - Federazione Russa 322
IN - India 155
MX - Messico 110
CA - Canada 75
JP - Giappone 61
AR - Argentina 55
BD - Bangladesh 53
PL - Polonia 46
NG - Nigeria 45
ZA - Sudafrica 40
NL - Olanda 39
EU - Europa 34
ES - Italia 32
BE - Belgio 28
IQ - Iraq 25
EC - Ecuador 19
ID - Indonesia 18
MA - Marocco 18
UZ - Uzbekistan 18
PK - Pakistan 17
AT - Austria 16
CZ - Repubblica Ceca 16
LT - Lituania 16
CO - Colombia 15
CH - Svizzera 14
VE - Venezuela 14
KE - Kenya 13
SA - Arabia Saudita 13
CL - Cile 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
CM - Camerun 9
EG - Egitto 9
AZ - Azerbaigian 7
NP - Nepal 7
RO - Romania 7
UY - Uruguay 7
AL - Albania 6
AU - Australia 6
DZ - Algeria 6
DK - Danimarca 5
OM - Oman 5
PE - Perù 5
PH - Filippine 5
TN - Tunisia 5
BO - Bolivia 4
IL - Israele 4
JO - Giordania 4
NZ - Nuova Zelanda 4
BB - Barbados 3
BY - Bielorussia 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KR - Corea 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
Totale 41.871
Città #
Milan 4.483
Jacksonville 1.798
Fairfield 1.768
Ashburn 1.496
San Jose 1.468
Chandler 1.411
Dallas 1.345
Singapore 1.330
Woodbridge 898
Hong Kong 840
Wilmington 762
Dearborn 694
Izmir 687
Cambridge 649
Houston 632
Seattle 632
Dublin 615
Princeton 600
Nyköping 525
Beijing 471
Ann Arbor 422
Dong Ket 382
Boardman 321
Rome 316
San Mateo 297
The Dalles 291
Lauterbourg 252
New York 205
Ho Chi Minh City 183
Chicago 180
San Diego 145
Hanoi 141
Los Angeles 140
Ogden 121
Munich 115
Helsinki 112
London 107
Orem 98
Santa Clara 92
Düsseldorf 91
Como 81
Mexico City 78
Guangzhou 73
Tokyo 60
Hefei 56
São Paulo 55
Washington 54
Frankfurt am Main 52
Chennai 49
Turku 48
Kunming 47
Des Moines 46
Nanjing 46
Abuja 45
Norwalk 43
Verona 41
Warsaw 41
Tianjin 38
Kocaeli 35
Philadelphia 34
Buffalo 31
Johannesburg 31
Montreal 30
Shanghai 30
Jinan 29
Council Bluffs 28
Manchester 28
Shenzhen 28
Brooklyn 27
Brussels 27
Zhengzhou 27
Rio de Janeiro 26
Stockholm 26
Haiphong 25
Atlanta 24
Berlin 23
Denver 23
San Francisco 23
Amsterdam 22
Nanchang 22
Boston 21
Poplar 21
Da Nang 20
Mumbai 20
Phoenix 20
Toronto 19
Shenyang 18
Belo Horizonte 16
Pune 16
Curitiba 15
Fuzhou 15
Nuremberg 15
Redwood City 15
Stuttgart 15
Auburn Hills 14
Hangzhou 14
Brno 13
Bắc Ninh 13
Brasília 12
Changsha 12
Totale 28.991
Nome #
1-year statin treatment reverts the pro-inflammatory cytokine interleukin-8 release of primed neutrophils in dyslipidemic subjects 1.163
Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study) 238
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease 233
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 222
Peripheral CD4+CD25+ Regulatory T-cell Frequency is Increased in High-Cardiovascular-Risk Subjects and is not Modified after 1-month Statin Treatment: a Longitudinal Study. 219
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines. 217
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? 215
Venous and arterial thrombosis in patients with HIV infection 209
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 208
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism. 205
Ambulatory blood pressure monitoring and atrial natriuretic peptide in normotensive and mild hypertensive subjects 204
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study 203
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality 202
An unusual case presenting with hypertensive crisis. 201
Statins, fibrates, and venous thromboembolism: a meta-analysis. 199
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 197
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 196
Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan)in patients with diabetes and hypertension 193
24-hour blood pressare profile and left ventricular anatomy and function in untreated hypertensives with and without microalbuminuria 192
Effects of dual blockade of renin-angiotensin system on concentric left ventricular hypertrophy in essential hypertension: A randomized, controlled pilot study 189
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis 188
Treatment with enalapril modifies the pain perception pattern in hypertensive patients. 188
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays 183
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT 183
JAK2 mutation and atypical chronic myeloid leukemia 183
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism. 182
Aldosterone antagonist improves left ventricular diastolic function: a randomized, controlled study in essential hypertensives. 180
Acute neutrophil count is a predictor of worst short and long-term outcome in spontaneous intracerebral haemorrhage. 180
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 178
Relationship between a genetic predisposition to hypertension, blood pressure levels and pain sensitivity 178
POST-PRANDIAL GLYCEMIA DOES NOT INFLUENCE LEFT VENTRICULAR MORPHOLOGY AND FUNCTION IN NON-DIABETIC ESSENTIAL HYPERTENSIVES 177
ORAL VITAMIN K LOWERS THE INTERNATIONAL NORMALIZED RATIO MORE RAPIDLY THAN SUBCUTANEOUS VITAMIN K IN THE TREATMENT OF WARFARIN-ASSOCIATED COAGULOPATHY 177
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study 177
Angiotensin-converting enzyme inhibitors influence left ventricular mass and function independently of the antihypertensive effect 175
Isolated office hypertension: a 3 year follow-up study. 174
Lack of relationship between cardiovascular reactivity to mental stress and autonomic modulation of the sinoatrial node in normotensive and hypertensive male subjects 174
Family history of hypertension hyperinsulinemia and left ventricular function in lean and obese hypertensives 174
Laminar pattern of mineral calcium-phosphorus deposits in a human carotid plaque: nanoscale ultrastructure and elemental analysis 173
Acute neutrophil count is a predictor of worst short-and long-term outcome in spontaneous intracerebral haemorrahge 173
Genetic predisposition to hypertension influences left ventricular changes during antihypertensive therapy 172
Relationship between left ventricular diastolic function and atrial natriuretic factor in never-treated mild hypertensives. 172
OSA, metabolic syndrome and CPAP: Effect on cardiac remodeling in subjects with abdominal obesity. 172
24-hour non-invasive blood pressure monitoring and pain sensitivity 172
“Patterns” di deposito di calico-fosforo nelle placche carotidee nell’uomo. 172
Angiotensin II Type1 and type2 receptor expression in circulating monocytes of diabetic patients over 3-month rosuvastatin treatment 172
Simvastatin treatment in subjects at high cardiovascular risk modulates AT(1)R expression on circulating monocytes and T lymphocytes 171
Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. 171
Abnormal response to handgrip in hypertensive patients with increased left ventricular mass, assessed by echocardiography. 171
Atorvastatin treatment influences polymorphonuclear leukocyte function: a longitudinal study. 171
Effects of atorvastatin treatment on the modulation of leukocyte function in patients undergoing peripheral vascular intervention: a longitudinal study 170
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 170
HOW MANY ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION CAN ACTUALLY BE TREATED WITH ORAL ANTICOAGULANTS? 169
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging. 169
Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies 169
Circadian blood pressure variability is associated with autonomic and baroreflex-mediated modulation of the sinoatrial node 168
Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly-diagnosed never-treated hypertensives. 168
Produzione di Tumor Necrosis Factor-a; e Interleuchina-4 dai linfociti circolanti e di Interleuchina-8 dai neutrofili in pazienti con sindrome delle apnee notturne: variazioni durante terapia notturna con pressione continua positiva nelle vie aeree. 167
Insulin sensitivity in obese normotensive adults: influence of family history of hypertension 166
Left ventricular anatomy and function in „white coat“ hypertensives: comparison with normotensives and never-treated ambulatory hypertensives. 166
Effects of sustained-release isradipine on left ventricular anatomy and function in systemic hypertension. 166
Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: a one year follow-up study. 165
CD4+CD25+ regulatory T cell population in atherosclerosis: pharmacological modulation. 165
Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement 164
Glycemic control in type 2 diabetes mellitus : relationship with left ventricular diastolic dysfunction and matrix metalloproteinases 164
Mental stress test-induced changes in pain sensitivity and haemodynamic variables. 163
Left ventricular remodelling in asymptomatic HIV infection on chronic HAART: comparison between hypertensive and normotensive subjects with and without HIV infection. 163
Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade 162
Association of cardiomyopathy with Kugelberg-Welander disease. 162
Ambulatory monitoring in hypertensive patients: correlation between the first three hour elevation and the nocturnal pressure fall. 162
Il trattamento con rosuvastatina è associato ad una riduzione dell’espressione del recettore di tipo 1, ma non di tipo 2, dell’Angiotensina II in monociti circolanti di pazienti diabetici. 162
Natriuretic peptides as markers of preclinical cardiac disease in obesity 162
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia 161
Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. 161
Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function 160
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement. 160
Systematic Review: Neutrophils and Clinical Outcomes in Patients With Acute Coronary Syndromes and/or Cardiac Revascularization. 160
AORTIC STIFFNESS IN NEVER - TREATED HYPERTENSIVES: LACK OF RELATION WITH MYOCARDIAL HYPERTROPHY AND IMPAIRED LEFT VENTRICULAR RELAXATION 159
Relation of extent of nocturnal blood pressure decrease to cardiovascular remodeling in never-treated patients with essential hypertension. 159
Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus 158
Patients with type 2 diabetes vs. non-diabetic high-risk subjects: effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes 158
Tumor necrosis factor-alpha and interleukin-4 production by circulating lymphocytes and interleukin-8 release by neutrophilis in patients with and without obstructive sleep apnea syndrome 158
Plasma matrix metalloproteinase (MMP)-9 and tissue inhibitor of MMPS (TIMP)-1 in hypertension: a meta-analysis. 158
CHRONIC TREATMENT WITH ACE-INHIBITORS INDUCES LEFT VENTRICULAR CHANGES INDEPENDENTLY OF BLOOD PRESSURE DECREASE 157
Left ventricular changes induced by chronic treatment with ACE-inhibitors independently of blood pressure effects 157
The effect of thyroid autoantibodies on warfarin stability. 157
Systematic review: neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularization. 157
Autonomic function and baroreflex sensitivity during a normal ovulatory cycle in humans. 157
Metabolic syndrome and morpho-functional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. 156
Left ventricular anatomy and function in normotensive young adults with hypertensive parents: study at rest and during handgrip. 156
Endothelial cell dysfunction in patients with peripheral artery disease. 155
Microalbuminuria as a marker of preclinical diastolic dysfunction in never-treated essential hypertensives. 155
Cytokine Production by Circulating Lymphocytes and Neutrophils in Patients with and without Obstructive Sleep Apnea Syndrome 155
Microhomologiee and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia. 154
Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study. 154
Hyperinsulinemia, family history of hypertension and essential hypertension 153
Effetto del trattamento con simvastatina sulla funzione dei leucociti polimorfonucleati in soggetti ad alto rischio cardiovascolare 152
Chronic treatment with ace-inhibitors induces left ventricular changes independently of blood pressure decrease. 152
Mixed cranial nerve neuroma revealing itself as baroreflex failure 151
Angiotensin II Reduces the Suppressive Function of Human CD4+CD25+ Regulatory T Lymphocytes. 151
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia 150
Totale 18.391
Categoria #
all - tutte 154.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.207 0 0 0 0 0 0 0 0 0 163 354 690
2021/20223.129 266 458 309 241 157 45 143 193 182 448 270 417
2022/20233.589 378 186 213 438 281 851 1 459 542 82 74 84
2023/20246.945 1.161 1.057 1.197 1.325 1.252 540 32 74 185 33 28 61
2024/20253.937 25 54 754 97 118 238 152 264 390 305 323 1.217
2025/20269.302 722 775 1.054 1.370 738 667 2.193 495 947 341 0 0
Totale 41.978